The dog is able to synthesise ascorbic acid (AA), but is frequently given t
he vitamin in an attempt to improve health and performance. Thc pharmacokin
etics Of AA in this species, however, are not well studied. Using a selecti
ve analytical method and careful stability control, the pharmacokinetics of
orally given AA was studied in 20 dogs, at two dosage levels (15 and 50 mg
kg(-1)) and with two forms of supplement [crystalline AA and the vitamin C
product Ester-C (R) (Inter-Cal Corp., Prescott, AZ, USA)]. After oral admi
nistration, a rapid increase was found in the plasma level Of AA, indicatin
g a possible intestinal active transport mechanism in this species. The obt
ained Cm,., and AUC values were found to increase in a non-linear fashion w
hen the dose Of AA was increased. The pharmacokinetic modeling of the elimi
nation Of AA was made difficult by a pronounced secondary peak appearing af
ter about 9 hours. The comparison of crystalline AA and Ester-C (R) did not
indicate any significant differences in pharmacokinetic parameters between
the two preparations of the vitamin. (C) 2001 Harcourt Publishers Ltd.